Restless legs syndrome: Keys to recognition and treatment

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 9, 2005, Pages 769-787

  Avecillas, Jaime F ^a   Golish, Joseph A ^a   Giannini, Carmen ^a   Yataco, José C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; DEXTROPROPOXYPHENE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; FERROUS SULFATE; FLUOXETINE; FOLIC ACID; GABAPENTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVODOPA; LITHIUM; MIANSERIN; MIRTAZAPINE; NARCOTIC ANALGESIC AGENT; OPIATE DERIVATIVE; PAROXETINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZONISAMIDE;

ABDOMINAL PAIN; ACUPUNCTURE; AKATHISIA; ANAMNESIS; ANOREXIA; CLINICAL TRIAL; CONSTIPATION; DATA ANALYSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FATIGUE; FIBROSIS; GASTROINTESTINAL SYMPTOM; HANGOVER; HEADACHE; HEREDITY; HUMAN; INSOMNIA; IRON DEFICIENCY; KIDNEY FAILURE; LEG CRAMP; MEDICAL DECISION MAKING; MIGRAINE; MOTOR DYSFUNCTION; NAUSEA; NEUROPATHY; NOSE CONGESTION; PARESTHESIA; PERICARDIAL DISEASE; PLEURAL FIBROSIS; PREGNANCY; PREVALENCE; PRURITUS; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; RELAXATION TRAINING; RESTLESS LEGS SYNDROME; RETROPERITONEAL FIBROSIS; REVIEW; SLEEP DISORDER; SOMNOLENCE; SYMPTOMATOLOGY; TREATMENT PLANNING; VALVULAR HEART DISEASE; XEROSTOMIA;

EID: 25844523301     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.9.769     Document Type: Review

References (95)

1. Ekbom KA. Restless legs syndrome. Acta Med Scand 1945; 158(suppl):1-123.
2. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28:372-378.
3. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4:101-119.
4. Winkelmann J, Wetter TC, Collado-Seidell V et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000; 23:597-602.
5. Tan EK, Ondo W. Restless legs syndrome: clinical features and treatment. Am J Med Sci 2000; 319:397-403.
6. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003; 61:304-309.
7. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56:263-265.
8. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54:1698-1700.
9. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53:547-554.
10. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160:2137-2141.
11. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001; 16:1159-1163.
12. Egan D, O'Dubhghaill C, McNamee S, Mulkerrin E, O'Keefe ST. A community study of the prevalence of restless legs. Ir Med J 2003; 96:153.
13. Ulfberg J, Nystrom B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001; 46:17-19.
14. Walters AS, Picchieitti D, Hening W, Lazzarini A. Variable expressivity in familial restless legs syndrome. Arch Neurol 1990; 47:1219-1220.
15. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996; 47:1435-1441.
16. Montplaisir J, Boucher S, Poirier G, LaVigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Discord 1997; 12:61-65.
17. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000; 55:1115-1121.
18. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000; 1:11-19.
19. Ondo WG, Vuong KD, Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000; 55:1404-1406.
20. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001; 69:1266-1270.
21. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003; 126:1485-1492.
22. Sun ER, Chen CA, Ho G, Eariey CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998; 21:371-377.
23. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23:200-203.
24. Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 36:783-788.
25. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001; 10:335-341.
26. Goodman JD, Brodie C, Ayida GA. Restless leg syndrome in pregnancy [letter]. BMJ 1988; 297:1101-1102.
27. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996; 19:670-672.
28. Botez MI, Lambert B. Folate deficiency and restless-legs syndrome in pregnancy. N Engl J Med 1977; 297:670.
29. Banerji NK, Hurwitz LJ. Restless legs syndrome, with particular reference to its occurrence after gastric surgery. Br Med J 1970; 4:774-775.
30. Reynolds G, Blake DR, Pall HS, Williams A. Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) 1986; 292:659-660.
31. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 1996; 312:1339.
32. O'Keefe ST. Restless legs syndrome. Arch Intern Med 1996; 156:243-248.
33. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003; 18:181-185.
34. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000; 54:1064-1068.
35. Hogl B, Frauscher B, Seppi K, Ulmer H, Poewe W. Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology 2002; 59:1705-1707.
36. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993; 69:701-703.
37. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with restless legs syndrome. Mov Discord 2000; 15:289-293.
38. Valentino RM, Lim L, Foldvary-Schaefer N. Periodic limb movements during nocturnal wakefulness in restless legs syndrome [abstract]. Sleep 2005; 28:A265.
39. Fukunishi I, Kitaoka T, Shirai T, Kino K. Facial paresthesias resembling restless legs syndrome in a patient on hemodialysis [letter]. Nephron 1998; 79:485.
40. Fahn S. Hypokinesia and hyperkinesia. In: Goetz CG. Textbook of Clinical Neurology. 2nd ed. Philadelphia: Elsevier Science (USA); 2003:279-297.
41. Walters AS, Hening W, Rubinstein M, Chokroverty S. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep 1991; 14:339-345.
42. LaBan MM, Viola SL, Femminineo AF, Taylor RS. Restless legs syndrome associated with diminished cardiopulmonary compliance and lumbar spinal stenosis - a motor concomitant of "Vesper's curse." Arch Phys Med Rehabil 1990; 71:384-388.
43. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004; 62:1563-1567.
44. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953; 145:453-457.
45. Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000; 43:70-75.
46. National Heart, Lung, and Blood Institute Working Group on Restless Legs Syndrome. Restless legs syndrome: detection and management in primary care. Am Fam Phys 2000; 62:108-114.
47. Benz RL, Pressman MR, Hovick ET, Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000; 35:1052-1060.
48. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002; 17:1072-1076.
49. Yataco J, Masri FA, Golish JA. Prevalence of restless legs syndrome in lung transplantation patients. Chest. In press.
50. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002; 35:109-111.
51. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999; 19:478-479.
52. Hargrave R, Beckley DJ. Restless leg syndrome exacerbated by sertraline. Psychosomatics 1998; 39:177-178.
53. Sanz-Fuentenebro FJ, Huidobro A, Tejadas-Rivas A. Restless legs syndrome and paroxetine. Acta Psychiatr Scand 1996; 94:482-484.
54. Bakshi R. Fluoxetine and restless legs syndrome. J Neurol Sci 1996; 142:151-152.
55. Bahk WM, Pae CU, Chae JH, Jun TY, Kim KS. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci 2002; 56:209-210.
56. Paik IH, Lee C, Choi BM, Chae YL, Kim CE. Mianserin-induced restless legs syndrome. Br J Psychiatry 1989; 155:415-417.
57. Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res 2002; 7:368-378.
58. Scherbaum N, Stuper B, Bonnet U, Gastpar M. Transient restless legs-like syndrome as a complication of opiate withdrawal. Pharmacopsychiatry 2003; 36:70-72.
59. Chen JT, Garda PA, Alldredge BK. Zonisamide-induced restless legs syndrome. Neurology 2003; 60:147.
60. Terao T, Terao M, Yoshimura R, Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry 1991; 30:1167-1170.
61. Jinsheng H. Acupuncture treatment of restless leg syndrome. J Tradit Chin Med 2001; 21:312-316.
62. Trenkwalder C, Stiasny K, Pollmacher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995; 18:681-688.
63. Von Scheele C. Levodopa in restless legs. Lancet 1986; 2:426-427.
64. Saletu M, Anderer P, Hogl B, et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm 2003; 110:611-626.
65. Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up. Arch Neurol 1990; 47:1223-1224.
66. Guilleminault C, Cetel M, Philil P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993; 43:445.
67. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19:205-213.
68. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52:944-950.
69. Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolicle in restless legs syndrome. Neurology 1998; 51:1599-1602.
70. Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001; 56:1399-1402.
71. Pfitzenmeyer P, Foucher P, Dennewald G, et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996; 9:1013-1019.
72. Shaunak S, Wilkins A, Pilling JB, Dick DJ. Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide. Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide. J Neurol Neurosurg Psychiatry 1999; 66:79-81.
73. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77:1280-1286.
74. Stiasny K, Robbecke J, Schuler P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - an open clinical trial. Sleep 2000; 23:349-354.
75. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999; 52:938-943.
76. Saietu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 2002; 252:185-194.
77. Adler CH, Hauser R, Sethi K, Caviness JN, Marlor L, Hentz JG. Ropinirole is beneficial for restless legs syndrome: a placebo-controlled crossover trial [abstract]. Neurology 2003; 60(suppl 1):A439.
78. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12-week, randomized, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75:92-17.
79. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 2000; 7(suppl 1):27-31.
80. Hening WA, Walters A, Kavey N, Gidro-Frank S, Cote L, Fahn S. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids. Neurology 1986; 36:1363-1366.
81. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16:327-332.
82. Allen RP, Kaplan PW, Buchholz DW, Earley CJ, Walters X. Double-blinded, placebo controlled comparison of high dose propoxyphene and moderate dose carbidopa/levodopa for treatment of periodic limb movements in sleep. Sleep Res 1992; 21:166.
83. Kaplan P, Allen R, Buchholz D, Walters J. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 1993; 16:717-723.
84. Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16:1105-1109.
85. Read DJ, Feast TG, Nassim MA. Clonazepam: effective treatment for restless legs syndrome in uraemia. Br Med J (Clin Res Ed) 1981; 283:885-886.
86. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984; 69:428-430.
87. Chesson AL Jr, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22:961-968.
88. Happe S, Klosch G, Saletu B, Zeitlhofer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001; 57:1717-1719.
89. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59:1573-1579.
90. Thorp ML, Morris CD, Bagby SP. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 2001; 38:104-108.
91. Telstad W, Sorensen O, Larsen S, Lillevold PE, Stensrud P, Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed) 1984; 288:444-446.
92. Wagner ML, Walters AS, Coleman RG, Hening WA, Grasing K, Chokroverty S. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 1996; 19:52-58.
93. Derom E, Elinck W, Buylaert W, van der Straeten M. Which beta-blocker for the restless leg? Lancet 1984; 1:857.
94. Evidente VG, Adler CH, Caviness JN, Hentz JG, Gwinn-Hardy K. Amantadine is beneficial in restless legs syndrome. Mov Disord 2000; 15:324-327.
95. Littner MR, Kushida C, McDowell Anderson W, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2004; 27:557-600.